Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYTOKINETICS INCCYTK · Entity 3528 | SVP Finance & CFO | March 06, 2023 | March 07, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYTOKINETICS INC
Report date March 06, 2023 · Filed March 07, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 87,346 |
Reported balance
After 2023-03-06 transaction · row 1
1 source rowRow 1 · 2023-03-06 · Grant · Acquired 30,000 · Balance 87,346 F1: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant. |
| Incentive Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.13 · Expires 2033-03-06 | Direct | 2,555 |
Reported balance
After 2023-03-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-03-06 · Grant · Acquired 2,555 · Balance 2,555 F2: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.13 · Expires 2033-03-06 | Direct | 47,445 |
Reported balance
After 2023-03-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-03-06 · Grant · Acquired 47,445 · Balance 47,445 F2: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant.
F2: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2023 Filed Mar 7, 2023 21:15 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 47,445 | $0.00 Strike: $39.13 | $0.00 |
DisclosureSEC source: 0001127602-23-009285 · form4.xml · derivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,445 Underlying: Common Stock · 47,445 shares Expires 2033-03-06 F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 21:15 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (Right to Buy) · Derivative | 2,555 | $0.00 Strike: $39.13 | $0.00 |
DisclosureSEC source: 0001127602-23-009285 · form4.xml · derivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,555 Underlying: Common Stock · 2,555 shares Expires 2033-03-06 F2 · kind: This option shall vest and become exercisable in equal monthly installments over 4 years commencing on April 6, 2023, with the final installment vesting on April 6, 2027. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 21:15 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-009285 · form4.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,346 F1 · kind: Award comprised of Restricted Stock Units that will vest over 3-years, with 40% vesting on the 1-year anniversary of the date of grant, an additional 40% vesting on the 2-year anniversary of the date of grant, and the remaining 20% vesting on the 3-year anniversary of the date of grant. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 21:05 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 2,403 | $39.13 | $94,029.39 |
DisclosureSEC source: 0001127602-23-009266 · form4.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,346 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 6, 2023, and does not represent a sale by the reporting person. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:13 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 6,225 | $39.60 | $246,510.00 |
DisclosureSEC source: 0001127602-23-008861 · form4.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,749 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 2, 2023, and does not represent a sale by the reporting person. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 22:47 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 1,210 | $44.13 | $53,397.30 |
DisclosureSEC source: 0001127602-23-005918 · form4.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,974 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on February 16, 2023 and does not represent a sale by the reporting person. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:42 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionIncentive Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $12.10 | $0.00 |
DisclosureSEC source: 0001127602-23-003808 · form4.xml · derivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,056 Underlying: Common Stock · 15,000 shares Expires 2027-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:42 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 15,000 | $45.00 | $675,000.00 |
DisclosureSEC source: 0001127602-23-003808 · form4.xml · nonDerivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,184 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2022. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 21:42 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 15,000 | $12.10 | $181,500.00 |
DisclosureSEC source: 0001127602-23-003808 · form4.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2022. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 23:12 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $12.10 | $0.00 |
DisclosureSEC source: 0001061983-22-000095 · edgardoc.xml · derivative · entry 6 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,944 Underlying: Common Stock · 10,000 shares Expires 2027-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 23:12 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 10,000 | $42.00 | $420,000.00 |
DisclosureSEC source: 0001061983-22-000095 · edgardoc.xml · nonDerivative · entry 4 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,109 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 23:12 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 10,000 | $12.10 | $121,000.00 |
DisclosureSEC source: 0001061983-22-000095 · edgardoc.xml · nonDerivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 23:12 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $12.10 | $0.00 |
DisclosureSEC source: 0001061983-22-000095 · edgardoc.xml · derivative · entry 5 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,944 Underlying: Common Stock · 15,000 shares Expires 2027-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 23:12 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 15,000 | $40.00 | $600,000.00 |
DisclosureSEC source: 0001061983-22-000095 · edgardoc.xml · nonDerivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,109 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 23:12 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 15,000 | $12.10 | $181,500.00 |
DisclosureSEC source: 0001061983-22-000095 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| March 09, 2022 Filed Mar 9, 2022 23:27 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $12.10 | $0.00 |
DisclosureSEC source: 0001061983-22-000073 · edgardoc.xml · derivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,944 Underlying: Common Stock · 15,000 shares Expires 2027-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| March 09, 2022 Filed Mar 9, 2022 23:27 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 15,000 | $38.00 | $570,000.00 |
DisclosureSEC source: 0001061983-22-000073 · edgardoc.xml · nonDerivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,109 F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| March 09, 2022 Filed Mar 9, 2022 23:27 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 15,000 | $12.10 | $181,500.00 |
DisclosureSEC source: 0001061983-22-000073 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 22, 2021. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 23:46 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 5,510 | $36.83 | $202,933.30 |
DisclosureSEC source: 0001061983-22-000068 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,109 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/07/2022 and does not represent a sale by the reporting person. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:40 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 46,138 | $37.63 Strike: $37.63 | $1,736,172.94 |
DisclosureSEC source: 0001061983-22-000054 · edgardoc.xml · derivative · entry 4 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,138 Underlying: Common Stock · 46,138 shares Expires 2032-03-01 F3 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:40 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 3,862 | $37.63 Strike: $37.63 | $145,327.06 |
DisclosureSEC source: 0001061983-22-000054 · edgardoc.xml · derivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,862 Underlying: Common Stock · 3,862 shares Expires 2032-03-01 F3 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:40 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-22-000054 · edgardoc.xml · nonDerivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,619 F2 · kind: Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:40 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 3,458 | $37.63 | $130,124.54 |
DisclosureSEC source: 0001061983-22-000054 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,619 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/02/2022 and does not represent a sale by the reporting person. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 00:40 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 2,074 | $35.32 | $73,253.68 |
DisclosureSEC source: 0001061983-22-000038 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,077 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 02/28/2022 and does not represent a sale by the reporting person. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 00:47 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 3,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-22-000026 · edgardoc.xml · nonDerivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,151 F2 · kind: Comprised of restricted stock units (RSUs) issued upon conversion of certain PSUs granted to the Reporting Person on May 11, 2021. The satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into RSUs of the Issuer. These RSUs will vest in whole on February 16, 2023. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 00:47 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 1,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-22-000026 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,026 F1 · kind: On or about May 11, 2021, the Reporting Person was granted performance-based stock units (PSUs) of the Issuer, which upon satisfaction and certification of the performance metric resulted in a portion of the PSUs being converted into fully-vested shares of common stock of the Issuer. Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 22:47 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 35,687 | $35.73 | $1,275,185.73 |
DisclosureSEC source: 0001061983-21-000243 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,064 F1 · security: Amount of securities beneficially owned following reported transaction has been adjusted by 182 shares representing shares purchased pursuant to ESPP but that have not been previously reported. Reporting persons Form 4 filed on March 09, 2021 erroneously stated that the reported 88,492 shares owned following reporting persons transaction on March 08, 2021 included 727 shares of common stock purchased pursuant to ESPP, but in fact only 545 shares of common stock purchased pursuant to ESPP were included in that 88,492 share total. F2 · kind: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 15, 2021. F3 · balance_after: Includes 804 shares of common stock purchased pursuant to the Issuers 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 08, 2021 Filed Mar 9, 2021 23:55 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 4,150 | $19.19 | $79,638.50 |
DisclosureSEC source: 0001061983-21-000076 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,492 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/06/2021 and does not represent a sale by the reporting person. F2 · balance_after: Includes 727 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 21:57 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 34,879 | $19.42 Strike: $19.42 | $677,350.18 |
DisclosureSEC source: 0001061983-21-000059 · edgardoc.xml · derivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,879 Underlying: Common Stock · 34,879 shares Expires 2031-03-01 F3 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 21:57 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 10,121 | $19.42 Strike: $19.42 | $196,549.82 |
DisclosureSEC source: 0001061983-21-000059 · edgardoc.xml · derivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,121 Underlying: Common Stock · 10,121 shares Expires 2031-03-01 F3 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 21:57 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001061983-21-000059 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,642 F1 · kind: Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant. F2 · balance_after: Includes 727 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 00:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 1,384 | $19.66 | $27,209.44 |
DisclosureSEC source: 0001061983-21-000049 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,642 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 03/01/2021 and does not represent a sale by the reporting person. F2 · balance_after: Includes 727 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| February 26, 2021 Filed Mar 1, 2021 21:59 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Tax withholdingCommon Stock | 4,353 | $18.73 | $81,531.69 |
DisclosureSEC source: 0001061983-21-000041 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,026 F1 · kind: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on 02/26/2021 and does not represent a sale by the reporting person. F2 · balance_after: Includes 727 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · derivative · entry 9 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,833 Underlying: Common Stock · 7,500 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · derivative · entry 8 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,732 Underlying: Common Stock · 5,000 shares Expires 2029-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionIncentive Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $12.10 | $0.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · derivative · entry 7 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,056 Underlying: Common Stock · 15,000 shares Expires 2027-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 15,000 | $30.00 | $450,000.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · nonDerivative · entry 6 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,300 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 15,000 | $12.10 | $181,500.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · nonDerivative · entry 5 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 7,500 | $30.00 | $225,000.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · nonDerivative · entry 4 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,300 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 7,500 | $7.80 | $58,500.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · nonDerivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 5,000 | $30.00 | $150,000.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · nonDerivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,300 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| October 05, 2020 Filed Oct 6, 2020 00:23 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 5,000 | $7.14 | $35,700.00 |
DisclosureSEC source: 0001061983-20-000159 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 21, 2020 Filed Aug 21, 2020 21:41 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001061983-20-000145 · edgardoc.xml · derivative · entry 6 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,333 Underlying: Common Stock · 15,000 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 21, 2020 Filed Aug 21, 2020 21:41 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.14 | $0.00 |
DisclosureSEC source: 0001061983-20-000145 · edgardoc.xml · derivative · entry 5 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,732 Underlying: Common Stock · 10,000 shares Expires 2029-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 21, 2020 Filed Aug 21, 2020 21:41 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 15,000 | $25.00 | $375,000.00 |
DisclosureSEC source: 0001061983-20-000145 · edgardoc.xml · nonDerivative · entry 4 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,300 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 21, 2020 Filed Aug 21, 2020 21:41 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 15,000 | $7.80 | $117,000.00 |
DisclosureSEC source: 0001061983-20-000145 · edgardoc.xml · nonDerivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 21, 2020 Filed Aug 21, 2020 21:41 UTC | CYTOKINETICS INC CYTK · Entity 3528 | SaleCommon Stock | 10,000 | $25.00 | $250,000.00 |
DisclosureSEC source: 0001061983-20-000145 · edgardoc.xml · nonDerivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,300 F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| August 21, 2020 Filed Aug 21, 2020 21:41 UTC | CYTOKINETICS INC CYTK · Entity 3528 | Exercise / conversionCommon Stock | 10,000 | $7.14 | $71,400.00 |
DisclosureSEC source: 0001061983-20-000145 · edgardoc.xml · nonDerivative · entry 1 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on June 26, 2020. F2 · balance_after: Includes 648 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP). Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 20:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 50,408 | $14.40 Strike: $14.40 | $725,875.20 |
DisclosureSEC source: 0001061983-20-000061 · edgardoc.xml · derivative · entry 3 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,408 Underlying: Common Stock · 50,408 shares Expires 2030-03-05 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
| March 06, 2020 Filed Mar 9, 2020 20:32 UTC | CYTOKINETICS INC CYTK · Entity 3528 | GrantIncentive Stock Option (right to buy) · Derivative | 9,592 | $14.40 Strike: $14.40 | $138,124.80 |
DisclosureSEC source: 0001061983-20-000061 · edgardoc.xml · derivative · entry 2 Jaw Ching · CIK 0001710875 · SVP Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,592 Underlying: Common Stock · 9,592 shares Expires 2030-03-05 F2 · derivative.exercise_date: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.